OSI PHARMACEUTICALS INC (CIK: 0000729922) EDGAR, Information, Filings... CompaniesBIO.Com

OSI PHARMACEUTICALS INC

Mailing address
41 PINELAWN ROAD, MELVILLE, Delaware, 11747
Phone
631-962-2000
State location
New York
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Filings
N/A

OSI PHARMACEUTICALS INC (CIK: 0000729922) is an American company incorporated in the state of New York. Head office is located at 41 PINELAWN ROAD, MELVILLE, New York, 11747. Work in the industry 2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES. OSI PHARMACEUTICALS INC is a public company and trade via Over-The-Counter (OTC).

Old names:

ONCOGENE SCIENCE INC from 1994-15-Nov to 1997-07-Aug

Owner	Filings	Transaction Date	Type of Owner
Astellas Pharma Inc.	0001376684	Jun-03-2010	10 percent owner
Astellas US Holding, Inc.	0001456894	Jun-03-2010	10 percent owner
Ruby Acqusition, Inc.	0001484677	Jun-03-2010	10 percent owner
Friedman Linda F.	0001493827	Jun-03-2010	director
Shea Patrick Michael	0001493828	Jun-03-2010	director
Knowles Stephen	0001493829	Jun-03-2010	director
Fitzsimmons William E.	0001493832	Jun-03-2010	director
Epstein David M.	0001488668	Apr-01-2010	officer: Sr. VP and CSO, Oncology
Davies Angela M.	0001488772	Apr-01-2010	officer: Sr. VP and CMO, Oncology
Rachman Jonathan	0001471222	Sep-01-2009	officer: Sr VP, Diabetes/Obesity R&D
Legault Pierre	0001391045	Dec-29-2008	officer: Exec. VP, CFO & Treasurer
AMPER LINDA E	0001220024	Jul-02-2007	officer: VP Bus. Administration & HR
LEE KENNETH B JR	0001208570	Jun-13-2007	director
CAGNONI PABLO J	0001205703	Dec-13-2006	officer: VP & Chief Medical Officer
COSTA SANTO J	0001013419	Jun-14-2006	director
NIEMIEC DAVID W	0001102903	Jun-14-2006	director
BROWNE G MORGAN	0001111363	Jun-14-2006	director
KLEIN JOSEPH III	0001206369	Jun-14-2006	director
LOVENBERG WALTER M PHD	0001213100	Jun-14-2006	director
INGRAM ROBERT ALEXANDER	0001219890	Jun-14-2006	director
STEVENSON KATHARINE BERGHUIS	0001232227	Jun-14-2006	director
MEHTA VIREN	0001238969	Jun-14-2006	director
WHITE JOHN P	0001238970	Jun-14-2006	director
RICHMOND MARK	0001238971	Jun-14-2006	director
GRANNER DARYL K	0001238974	Jun-14-2006	director
PINEDO HERBERT MD PHD	0001293196	Jun-14-2006	director
ATIEH MICHAEL G	0001072501	Jun-13-2006	officer: Exec. VP & CFO
GIBSON NEIL	0001220036	Jun-13-2006	officer: VP & Chief Scientific Officer
SIMON ROBERT L	0001220050	Jun-13-2006	officer: Exec. VP, Core Dev. & Manf.
WOOD BARBARA A	0001220051	Jun-13-2006	officer: V.P. & General Counsel
LEUNG GABRIEL	0001236183	Jun-13-2006	officer: Exec. VP, Pres., (OSI) Onc.
LUNDEMOSE ANKER MD, PH.D, DSC	0001314821	Jun-13-2006	officer: Exec. VP & Pres. OSI Prosidion
GODDARD COLIN	0001225199	Jun-02-2006	director, officer: Chief Executive Officer
CHANEY PAUL G	0001277477	May-01-2006	officer: Exec. VP & Pres. (OSI) Eyetech
GUYER DAVID R	0001277476	Nov-14-2005	officer: Exec. VP & CEO (OSI) Eyetech
FRENCH JOHN H II	0001238973	Jan-21-2004	director
GEE EDWIN A	0001198760	Aug-14-2003	director
ONETTO NICOLE	0001220049	Jun-25-2003	officer: Executive VP, Oncology
VAN NOSTRAND ROBERT L	0001225198	Jun-25-2003	officer: VP, & Chief Financial Officer

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by OSI PHARMACEUTICALS INC

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001144204-11-008131 (34 Act) Size: KB	Feb-14-2011	005-37954 11604365
CT ORDER	Document	Acc-no: 9999999997-10-018958 (34 Act) Size: KB	Oct-19-2010	000-15190 101130343
SC TO-I/A	Document	Amendment to Issuer tender offer statement Acc-no: 0001341004-10-001341 (34 Act) Size: KB	Aug-05-2010	005-37954 10993943
SC TO-I/A	Document	Amendment to Issuer tender offer statement Acc-no: 0000950123-10-065261 (34 Act) Size: KB	Jul-13-2010	005-37954 10950713
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000902219-10-000978 (34 Act) Size: KB	Jul-12-2010	005-37954 10947827
UPLOAD	Document	Acc-no: 0000000000-10-037256 ( Act) Size: KB	Jul-02-2010
SC TO-I/A	Document	Amendment to Issuer tender offer statement Acc-no: 0000950123-10-062310 (34 Act) Size: KB	Jun-29-2010	005-37954 10924365
UPLOAD	Document	Acc-no: 0000000000-10-035699 ( Act) Size: KB	Jun-24-2010
SC TO-I/A	Document	Amendment to Issuer tender offer statement Acc-no: 0001341004-10-001058 (34 Act) Size: KB	Jun-18-2010	005-37954 10905874
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0000950123-10-059201 (34 Act) Size: KB	Jun-18-2010	000-15190 10905339
SC TO-I	Document	Issuer tender offer statement Acc-no: 0000950123-10-058864 (34 Act) Size: KB	Jun-17-2010	005-37954 10902719
EFFECT	Document	Acc-no: 9999999995-10-001807 (33 Act) Size: KB	Jun-14-2010	333-86624 10896213
EFFECT	Document	Acc-no: 9999999995-10-001789 (33 Act) Size: KB	Jun-14-2010	333-110938 10896220
EFFECT	Document	Acc-no: 9999999995-10-001806 (33 Act) Size: KB	Jun-14-2010	333-57784 10896210
EFFECT	Document	Acc-no: 9999999995-10-001788 (33 Act) Size: KB	Jun-14-2010	333-02451 10896216
EFFECT	Document	Acc-no: 9999999995-10-001805 (33 Act) Size: KB	Jun-14-2010	333-31474 10896205
EFFECT	Document	Acc-no: 9999999995-10-001792 (33 Act) Size: KB	Jun-14-2010	333-12593 10896207
EFFECT	Document	Acc-no: 9999999995-10-001791 (33 Act) Size: KB	Jun-14-2010	333-124279 10896202
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0001181431-10-032351 ( Act) Size: 0 KB	Jun-09-2010
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0001181431-10-032350 ( Act) Size: 0 KB	Jun-09-2010

Recent 20 filings. View all OSI PHARMACEUTICALS INC filings

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

OSI PHARMACEUTICALS INC overview
OSI PHARMACEUTICALS INC job
OSI PHARMACEUTICALS INC stock
OSI PHARMACEUTICALS INC ownership
OSI PHARMACEUTICALS INC CEO
OSI PHARMACEUTICALS INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.